Technology | EP Mapping and Imaging Systems | January 19, 2018

Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled

New device facilitates rapid, complex arrhythmia diagnosis and enables physicians to map any chamber of the heart to best determine ablation strategy and optimize patient care

Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled

January 19, 2018 — Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping Catheter, Sensor Enabled, a product designed to advance cardiac mapping during cardiac ablation to treat patients with complex cardiac arrhythmias. With the European launch of this latest addition to Abbott’s electrophysiology portfolio, the company is offering physicians a mapping catheter with what it calls a first-of-its-kind grid configuration of electrodes for improved data collection that supports the creation of high-density mapping of cardiac tissue to support optimal treatment for patients.

For patients battling complex arrhythmias, physicians may use cardiac ablation therapy to create tiny scars or lesions on the heart to stop erratic electrical signals. Yet to ensure the best outcomes for their patients, physicians first need to identify which areas of the heart are responsible for those signals.  Mapping catheters are critical to providing this insight.

Indicated for use in any chamber of the heart, the Advisor HD Grid mapping catheter is designed to combat challenges sometimes associated with traditional mapping catheters.

Linear or circular mapping catheters may experience signal disruptions as the orientation of the catheter changes. The Advisor HD Grid mapping catheter is intended to help physicians avoid signal loss by allowing for data to be captured horizontally and vertically along a new electrode grid configuration with 16 sensors. As a result, the catheter utilizes high-density mapping to create detailed and anatomically accurate 3-D models of the heart.

Abbott's Advisor HD Grid mapping catheter enables physicians to collect data simultaneously along the catheter’s grid pattern to help optimize treatment decisions. Combined with the EnSite Precision Cardiac Mapping System, the data captured by the catheter is used to create a highly detailed map highlighting the differences between healthy tissue and tissue responsible for a patient's cardiac arrhythmias, such as atrial fibrillation. Such detail can make an important impact on a physician's ablation strategy and approach to patient care.

As an added benefit for physicians, by designing the Advisor HD Grid mapping catheter as Sensor Enabled, Abbott has allowed the catheter to capture data in two ways – through impedance and magnetic collection, improving how data is collected and providing physicians additional flexibility when pairing the catheter with the EnSite Precision Cardiac Mapping System.

For more information: www.sjmglobal.com

 

Related Content

News | Ablation Systems

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

Home April 05, 2021
Home
News | Ablation Systems

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
Home
News | Ablation Systems

May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF) ...

Home May 08, 2020
Home
Feature | Ablation Systems

May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or ...

Home May 08, 2020
Home
Videos | Ablation Systems

Clifford Robinson, M.D., associate professor of radiation oncology, chief of the SBRT service, director of clinical ...

Home September 26, 2019
Home
News | Ablation Systems

September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically ...

Home September 17, 2019
Home
News | Ablation Systems

May 16, 2019 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter ...

Home May 16, 2019
Home
News | Ablation Systems

May 16, 2019 — CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the ...

Home May 16, 2019
Home
News | Ablation Systems

May 14, 2019 — The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an ...

Home May 14, 2019
Home
News | Ablation Systems

May 13, 2019 — Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands ...

Home May 13, 2019
Home
Subscribe Now